What does GISP mean in MEDICAL

The Gonococcal Isolate Surveillance Project (GISP) is a national sentinel surveillance system to detect emerging antimicrobial resistance among Neisseria gonorrhoeae strains in the United States. GISP provides resistance and susceptibility data to help inform clinical guidelines, public health policy and local treatment practices.

GISP has been active since 1986, providing critical data on the emergence of antimicrobial resistance among Neisseria gonorrhoeae strains in the United States.

The Centers for Disease Control and Prevention (CDC), state and local health departments, academic institutions, laboratories, clinicians, and medical/public health partners are all involved with the Gonococcal Isolate Surveillance Project.

GISP takes place in 26 participating jurisdictions across the United States that include California, Colorado, District of Columbia, Florida, Georgia, Illinois, Kansas City Metro Area (Missouri & Kansas), Maryland/DC-Delaware/Virginia (MDDV), Massachusetts, Michigan, Minnesota/Wisconsin (MW), New York City/Northern New Jersey (NYCNNJ), North Carolina Central Triangle Region (NCCTR), Ohio Valley Region (Ohio Valley Regions includes Indiana & Kentucky); Philadelphia Metro Area; Puerto Rico; San Diego County; Seattle Metro Region-Tacoma Metro Region; STD Clinical Trials Network 10 Cities Collaboration Sites; Tennessee Valley Region; Texas Gulf Coast; Twin Cities Metropolitan Area of Minnesota & Wisconsin; Washington State STD Control Program laboratory sites

The Gonococcal Isolate Surveillance Project collects antimicrobial susceptibility test results as well as clinical information on patients that may be used to inform medical decisions regarding antibiotic therapy. It also tracks trends in resistance patterns over time enabling healthcare providers and public health officials to adjust treatment recommendations accordingly.

The overall goal of GISP is to provide an early warning system for emerging drug resistant strains of Neisseria gonorrhoeae in order to prevent their spread. Data collected by the program can also be used to develop better treatment guidelines and protocols for managing cases of gonorrhea.

The Centers for Disease Control and Prevention provides funding for the Gonococcal Isolate Surveillance Project through its Division of Sexually Transmitted Diseases Treatment Programs. Additional funding is provided by state and local health departments throughout the U.S.

Data collected by GISP is used by researchers and public health officials to track emerging trends in drug-resistance patterns among Neisseria gonorrhoeae infections nationwide as well as develop better treatment guidelines and protocols for managing cases of gonorrhea.

Data collected from GISP is continually monitored on a national level for emerging drug resistant strains so it can be quickly identified when they arise. It is then analyzed quarterly in order to report findings regarding these strains in a timely manner.

After analysis has been completed by both laboratory technicians who analyze samples collected from participating sites as well as epidemiologists who interpret these findings into meaningful conclusions based off current evidence-based criteria concerning therapeutic management options available when treating cases of gonorrhea. Each jurisdiction then reports their findings back to CDC where they will be compiled into a final report which will be available online shortly thereafter for review by other stakeholders such as clinicians or researchers who need access to this information more quickly than disseminated through published literature associated with said outcomes.

Participation in gisp requires each jurisdiction's laboratory staffs meet certain criteria established by CDC which includes obtaining licensure maintenance according to federal regulations set forth under 42 CFR Part 493 - Laboratory Requirements Subpart A - General Requirements As Well As Proficiency testing requirements appropriate according this subpart before samples can be submitted for evaluation.